Zimmer Biomet Holdings, Inc. (ZBH)
Sector: Healthcare
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country: United States
Exchange: NYSE
Market cap: $18.37B
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Latest financial period: June 30, 2026
Filed with the SEC: August 5, 2026
Estimated earnings date: November 4, 2026
Profit #1045 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 5.4% | 5.6% | 5.4% | 6.0% |
Growth #869 of 1484 companies
Payout #479 of 1484 companies
Safety #52 of 1484 companies
Price #369 of 1484 companies
